Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
NRG Energy
NRG
$26.5B
| $5.3M | 0.01% |
138,116
-487,707
| -78% | -$19M |
|
1552
Atara Biotherapeutics
ATRA
$72.9M
| $5.29M | 0.01% |
+22,792
| New | +$7.26M |
|
1553
Ethan Allen Interiors
ETD
$581M
| $5.28M | 0.01% |
202,600
+58,100
| +40% | +$1.5M |
|
1554
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $5.28M | 0.01% |
96,900
+10,600
| +12% | +$580K |
|
1555
Aemetis
AMTX
$128M
| $5.26M | 0.01% |
415,085
-64,100
| -13% | -$706K |
|
1556
C&F Financial
CFFI
$287M
| $5.25M | 0.01% |
104,000
-2,700
| -3% | -$138K |
|
1557
Capital City Bank Group
CCBG
$898M
| $5.25M | 0.01% |
199,171
+11,900
| +6% | +$326K |
|
1558
Bank of Marin Bancorp
BMRC
$458M
| $5.24M | 0.01% |
149,492
+8,700
| +6% | +$317K |
|
|
LKFT
1559
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $5.24M | 0.01% |
84,500
+27,900
| +49% | +$1.71M |
|
|
PDCO
1560
DELISTED
Patterson Companies, Inc.
PDCO
| $5.24M | 0.01% |
161,804
+69,800
| +76% | +$2.07M |
|
1561
Daktronics
DAKT
$986M
| $5.22M | 0.01% |
1,360,404
+100,156
| +8% | +$460K |
|
|
ECOM
1562
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $5.21M | 0.01% |
314,600
+81,413
| +35% | +$1.54M |
|
|
HMLP
1563
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $5.21M | 0.01% |
706,410
-26,659
| -4% | -$124K |
|
1564
China Yuchai International
CYD
$1.7B
| $5.2M | 0.01% |
446,193
-27,200
| -6% | -$352K |
|
|
CTIC
1565
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.19M | 0.01% |
1,111,413
-244,000
| -18% | -$728K |
|
1566
Applovin
APP
$106B
| $5.18M | 0.01% |
+94,100
| New | +$5.99M |
|
1567
Unilever
UL
$134B
| $5.18M | 0.01% |
101,067
-333,350
| -77% | -$18.6M |
|
1568
MacroGenics
MGNX
$268M
| $5.16M | 0.01% |
+585,712
| New | +$6.47M |
|
1569
Grupo Aval
AVAL
$6.29B
| $5.16M | 0.01% |
1,133,952
-53,911
| -5% | -$290K |
|
|
AVDL
1570
DELISTED
Avadel Pharmaceuticals
AVDL
| $5.15M | 0.01% |
754,306
-91,500
| -11% | -$629K |
|
1571
STMicroelectronics
STM
$48.5B
| $5.15M | 0.01% |
118,581
-1,412,098
| -92% | -$62.4M |
|
1572
Companhia Siderúrgica Nacional
SID
$1.17B
| $5.13M | 0.01% |
946,500
-2,162,300
| -70% | -$10.7M |
|
1573
Benchmark Electronics
BHE
$2.94B
| $5.12M | 0.01% |
204,550
+44,000
| +27% | +$1.12M |
|
1574
HP
HPQ
$27.5B
| $5.12M | 0.01% |
+141,000
| New | +$5.21M |
|
1575
Select Water Solutions
WTTR
$2.69B
| $5.11M | 0.01% |
596,699
+44,302
| +8% | +$345K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.